ORKA
Oruka Therapeutics, Inc.
95.00$
-2.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Oruka Therapeutics, Inc. (ORKA) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/01/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/01/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/28/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 08/24/2026 | Current report (8-K) | Oruka Therapeutics, Inc. (ORKA): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/12/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/10/2026 | Current report (8-K) | Oruka Therapeutics, Inc. (ORKA): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/13/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.